Huperzine A protects sepsis associated encephalopathy by promoting the deficient cholinergic nervous function

Neuroscience Letters

Volumn 631, Issue , 2016, Pages 70-78

  Zhu, Sen zhi ^a,b,c   Huang, Wei ping ^b   Huang, Lin qiang ^b   Han, Yong li ^b   Han, Qian peng ^a   Zhu, Gao feng ^b   Wen, Miao yun ^b   Deng, Yi yu ^b   Zeng, Hong ke ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acetylcholine; Acetylcholinesterase; Choline acetyltransferase; Huperzine A; Muscarinic acetylcholine receptor 1; Sepsis associated encephalopathy

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTIINFLAMMATORY AGENT; CHOLINE ACETYLTRANSFERASE; HERBACEOUS AGENT; HUPERZINE A; INTERLEUKIN 1BETA; MESSENGER RNA; MUSCARINIC RECEPTOR; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; ALKALOID; CHOLINESTERASE INHIBITOR; LIPOPOLYSACCHARIDE; SESQUITERPENE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN FUNCTION; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HIPPOCAMPAL TISSUE; HUPERZIA; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; MALE; MEMORY; MORRIS WATER MAZE TEST; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS ASSOCIATED ENCEPHALOPATHY; SPATIAL LEARNING; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; ENCEPHALITIS; HIPPOCAMPUS; METABOLISM; SPATIAL MEMORY; WISTAR RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; ENCEPHALITIS; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SEPSIS-ASSOCIATED ENCEPHALOPATHY; SESQUITERPENES; SPATIAL LEARNING; SPATIAL MEMORY;

EID: 84982103488     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.07.009     Document Type: Article

References (34)

1. [1] Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M.R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29 (2001), 1303–1310.
2. [2] Sprung, C.L., Peduzzi, P.N., Shatney, C.H., Schein, R.M., Wilson, M.F., Sheagren, J.N., Hinshaw, L.B., Impact of encephalopathy on mortality in the sepsis syndrome. the veterans administration systemic sepsis cooperative study group. Crit. Care Med. 18 (1990), 801–806.
3. [3] Hopkins, R.O., Weaver, L.K., Chan, K.J., Orme, J.F. Jr., Quality of life emotional, and cognitive function following acute respiratory distress syndrome. J. Int. Neuropsychol. Soc. 10 (2004), 1005–1017.
4. [4] Calsavara, A.C., Rodrigues, D.H., Miranda, A.S., Costa, P.A., Lima, C.X., Vilela, M.C., Rachid, M.A., Teixeira, A.L., Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis. Neurotox. Res. 24 (2013), 103–108.
5. [5] Dal-Pizzol, F., Tomasi, C.D., Ritter, C., Septic encephalopathy: does inflammation drive the brain crazy?. Rev. Bras. Psiquiatr. 36 (2014), 251–258.
6. [6] Deiana, S., Platt, B., Riedel, G., The cholinergic system and spatial learning. Behav. Brain Res. 221 (2011), 389–411.
7. [7] Willard, L.B., Hauss-Wegrzyniak, B., Wenk, G.L., Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88 (1999), 193–200.
8. [8] Semmler, A., Frisch, C., Debeir, T., Ramanathan, M., Okulla, T., Klockgether, T., Heneka, M.T., Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 204 (2007), 733–740.
9. [9] Borovikova, L.V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G.I., Watkins, L.R., Wang, H., Abumrad, N., Eaton, J.W., Tracey, K.J., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000), 458–462.
10. [10] Lee, S.T., Chu, K., Jung, K.H., Kang, K.M., Kim, J.H., Bahn, J.J., Jeon, D., Kim, M., Lee, S.K., Roh, J.K., Cholinergic anti-inflammatory pathway in intracerebral hemorrhage. Brain Res. 1309 (2010), 164–171.
11. [11] Kolgazi, M., Uslu, U., Yuksel, M., Velioglu-Ogunc, A., Ercan, F., Alican, I., The role of cholinergic anti-inflammatory pathway in acetic acid-induced colonic inflammation in the rat. Chem. Biol. Interact. 205 (2013), 72–80.
12. [12] Pavlov, V.A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J.M., Czura, C.J., Al-Abed, Y., Tracey, K.J., Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 5219–5223.
13. [13] Wang, J., Zhang, H.Y., Tang, X.C., Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J. Neurosci. Res. 88 (2010), 807–815.
14. [14] Lukasz, B., O'Sullivan, N.C., Loscher, J.S., Pickering, M., Regan, C.M., Murphy, K.J., Peripubertal viral-like challenge and social isolation mediate overlapping but distinct effects on behaviour and brain interferon regulatory factor 7 expression in the adult Wistar rat. Brain Behav. Immun. 27 (2013), 71–79.
15. [15] Zeng, H.K., Wang, Q.S., Deng, Y.Y., Fang, M., Chen, C.B., Fu, Y.H., Jiang, W.Q., Jiang, X., Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes. Neuroscience 166 (2010), 878–885.
16. [16] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
17. [17] Zhang, L., Kong, L.T., Sun, L., Ye, L.H., Xiao, B.X., Cao, F.R., Liu, X.M., Chang, Q., Simultaneous determination of seven neurotransmitters in mice brain tissue by LC–MS/MS. Chin. J. Exp. Tradit. Med. Formulae 19 (2013), 132–136.
18. [18] Goehler, L.E., Relton, J.K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S.F., Watkins, L.R., Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 43 (1997), 357–364.
19. [19] Olofsson, P.S., Rosas-Ballina, M., Levine, Y.A., Tracey, K.J., Rethinking inflammation: neural circuits in the regulation of immunity. Immunol. Rev. 248 (2012), 188–204.
20. [20] Semmler, A., Hermann, S., Mormann, F., Weberpals, M., Paxian, S.A., Okulla, T., Schäfers, M., Kummer, M.P., Klockgether, T., Heneka, M.T., Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation, 5, 2008, 38.
21. [21] Berg, R.M., Møller, K., Bailey, D.M., Neuro-oxidative-nitrosative stress in sepsis. J. Cereb. Blood Flow Metab. 31 (2011), 1532–1544.
22. [22] Semmler, A., Okulla, T., Sastre, M., Dumitrescu-Ozimek, L., Heneka, M.T., Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J. Chem. Neuroanat. 30 (2005), 144–157.
23. [23] Willard, L.B., Hauss-Wegrzyniak, B., Danysz, W., Wenk, G.L., The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 134 (2000), 58–65.
24. [24] Tyagi, E., Agrawal, R., Nath, C., Shukla, R., Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain. J. Neuroimmunol. 205 (2008), 51–56.
25. [25] Li, Y., Liu, L., Kang, J., Sheng, J.G., Barger, S.W., Mrak, R.E., Griffin, W.S., Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20 (2000), 149–155.
26. [26] Rosas-Ballina, M., Valdés-Ferrer, S.I., Dancho, M.E., Ochani, M., Katz, D., Cheng, K.F., Olofsson, P.S., Chavan, S.S., Al-Abed, Y., Tracey, K.J., Pavlov, V.A., Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav. Immun. 44 (2015), 19–27.
27. [27] Puri, V., Wang, X., Vardigan, J.D., Kuduk, S.D., Uslaner, J.M., The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model. Behav. Brain Res. 287 (2015), 96–99.
28. [28] Huang, J., Wang, Y., Jiang, D., Zhou, J., Huang, X., The sympathetic-vagal balance against endotoxemia. J. Neural. Transm. 117 (2010), 729–735.
29. [29] van Gool, W.A., van de Beek, D., Eikelenboom, P., Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 375 (2010), 773–775.
30. [30] Cheng, D.H., Tang, X.C., Comparative studies of huperzine A E2020, and tacrine on behaviour and acetylcholinesterase activities. Pharmacol. Biochem. Behav. 60 (1998), 377–386.
31. [31] Wang, R., Zhang, H.Y., Tang, X.C., Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1–40) in rat. Eur. J. Pharmacol. 421 (2001), 149–156.
32. [32] Yan, H., Zhang, H.Y., Tang, X.C., Involvement of M1-muscarinic acetylcholine receptors, protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-alpha. Neuroreport 18 (2007), 689–692.
33. [33] Wang, R., Yan, H., Tang, X.C., Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin., 27, 2006, 126.
34. [34] Ma, T., Gong, K., Yan, Y., Zhang, L., Tang, P., Zhang, X., Gong, Y., Huperzine A promotes hippocampal neurogenesis in vitro and in vivo. Brain Res. 1506 (2013), 35–43.